Last quarter (Q2 2023), VBI Vaccines's total revenue was $720.00K, an increase of 108.09% from the same quarter last year. In Q2, VBI Vaccines's net income was $-44.63M. See VBI Vaccines’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 1.81M	$ 1.08M	$ 631.00K	$ 1.06M	$ 2.22M	$ 3.35M
Cost of Revenue	$ 2.67M	-	-	$ 9.17M	$ 7.90M	$ 4.51M
Gross Profit	$ -857.00K	$ 1.08M	$ 631.00K	$ -8.11M	$ -5.68M	$ -1.15M
Operating Expense	$ 15.17M	$ 82.90M	$ 68.66M	$ 35.51M	$ 40.42M	$ 58.98M
Operating Income	$ -57.98M	$ -81.82M	$ -68.03M	$ -43.62M	$ -46.11M	$ -60.13M
Net Non Operating Interest Income Expense	$ -5.13M	$ -4.01M	$ -4.73M	$ -2.71M	$ -2.20M	$ -2.63M
Other Income Expense	$ -2.87M	$ -66.00K	-	$ 95.00K	$ -6.51M	$ -838.00K
Pretax Income	$ -118.73M	$ -113.30M	$ -69.75M	$ -46.23M	$ -54.81M	$ -63.60M
Tax Provision	-	-	-	$ 0.00	$ 0.00	$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -78.74M	$ -113.30M	$ -69.75M	$ -46.23M	$ -54.81M	$ -63.60M
Basic EPS	$ -8.58	$ -0.44	$ -8.10	$ -0.21	$ -0.46	$ -0.97
Diluted EPS	$ -8.50	$ -0.44	$ -8.10	$ -0.21	$ -0.46	$ -0.97
Basic Average Shares	$ 533.73M	$ 258.26M	$ 8.50M	$ 218.27M	$ 119.45M	$ 65.65M
Diluted Average Shares	$ 275.47M	$ 258.26M	$ 8.50M	$ 218.27M	$ 119.45M	$ 65.65M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 17.84M	$ 82.90M	$ 68.66M	$ 44.68M	$ 48.33M	$ 63.48M
Interest Expense	$ 1.27M	-	-	$ 3.32M	$ 3.03M	$ 3.25M
Net Income From Continuing And Discontinued Operation	$ -118.73M	$ -113.30M	$ -69.75M	$ -46.23M	$ -54.81M	$ -63.60M
Normalized Income	$ -37.60M	$ -89.50M	-	$ -46.33M	$ -48.30M	$ -62.76M
EBIT	$ -113.11M	$ -109.30M	$ -65.02M	$ -42.91M	$ -51.78M	$ -60.35M
EBITDA	$ -71.22M	$ -105.53M	$ -69.86M	$ -41.26M	$ -50.58M	$ -59.80M

Currency in USD

VBI Vaccines Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing